As a result, Bifidobacterium enhances antitumor immune responses and improves the effectiveness of anti-CD274 immunotherapy through increased trafficking, penetration, and infiltration of effector T CD8+ cells into tumor tissue which is considered as one of the most important challenges in cancer immunotherapy. The gene discussed is CD8A; the disease is neoplasm.